← Open Payments lookup

JODY BECK: Open Payments

NPI 1346727815 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,080 in 45 payments from 26 companies in 2025. Trend: 2023 $147 · 2024 $609 · 2025 $1,080

Food & beverage: $1,080
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation10$252
Merck Sharp & Dohme LLC4$109
ABBVIE INC.3$72
Regeneron Healthcare Solutions, Inc.3$66
Janssen Biotech, Inc.2$56
AstraZeneca Pharmaceuticals LP2$51
BeiGene USA, Inc.2$46
GlaxoSmithKline, LLC.1$35
Takeda Pharmaceuticals U.S.A., Inc.1$32
PharmaEssentia USA Corporation1$32

Products named: KISQALI, KEYTRUDA, LIBTAYO, Fabhalta, Venclexta, JEMPERLI, SCEMBLIX, ELAHERE.

Industry payments across DC — which companies pay providers there.